lexingtonbiologo.jpg
Lexington Receives Approval to Commence Clinical Study
24 janv. 2018 09h00 HE | Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...